Testing effectiveness (Phase 2)Study completedNCT05496231
What this trial is testing
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
Who this might be right for
Cervical Intraepithelial Neoplasia
GlaxoSmithKline 1,080